Business Segments · Supplies Expense

Biopharma Laboratory Services — Supplies Expense

Labcorp Holdings Biopharma Laboratory Services — Supplies Expense increased by 3.8% to $121.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.4%, from $111.10M to $121.50M. Over 3 years (FY 2022 to FY 2025), Biopharma Laboratory Services — Supplies Expense shows relatively stable performance with a 1.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2026

How to read this metric

An increase in supplies expense relative to revenue may signal rising material costs or lower operational efficiency in testing.

Detailed definition

This represents the costs of materials, reagents, and other consumables required to perform laboratory tests and service...

Peer comparison

Common variable cost metric for clinical and diagnostic laboratory businesses.

Metric ID: lh_segment_biopharma_laboratory_services_supplies_expense

Historical Data

17 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$115.15M$115.15M$115.15M$115.15M$113.05M$113.05M$113.05M$113.05M$103.50M$106.70M$109.50M$122.20M$111.10M$130.80M$119.50M$117.10M$121.50M
QoQ Change+0.0%+0.0%+0.0%-1.8%+0.0%+0.0%+0.0%-8.4%+3.1%+2.6%+11.6%-9.1%+17.7%-8.6%-2.0%+3.8%
YoY Change-1.8%-1.8%-1.8%-1.8%-8.4%-5.6%-3.1%+8.1%+7.3%+22.6%+9.1%-4.2%+9.4%
Range$103.50M$130.80M
CAGR+1.4%
Avg YoY Growth+2.1%
Median YoY Growth-1.8%

Frequently Asked Questions

What is Labcorp Holdings's biopharma laboratory services — supplies expense?
Labcorp Holdings (LH) reported biopharma laboratory services — supplies expense of $121.50M in Q1 2026.
How has Labcorp Holdings's biopharma laboratory services — supplies expense changed year-over-year?
Labcorp Holdings's biopharma laboratory services — supplies expense increased by 9.4% year-over-year, from $111.10M to $121.50M.
What is the long-term trend for Labcorp Holdings's biopharma laboratory services — supplies expense?
Over 3 years (2022 to 2025), Labcorp Holdings's biopharma laboratory services — supplies expense has grown at a 1.3% compound annual growth rate (CAGR), from $460.60M to $478.50M.
What does biopharma laboratory services — supplies expense mean?
The cost of materials and supplies used to conduct laboratory tests in this segment.